Neuroprotective effects of IGF-I against TNFα-induced neuronal damage in HIV-associated dementia

Virology

Volumn 305, Issue 1, 2003, Pages 66-76

  Wang, Jin Ying ^a   Peruzzi, Francesca ^a   Lassak, Adam ^a   Del Valle, Luis ^a   Radhakrishnan, Sujahata ^a   Rappaport, Jay ^a   Khalili, Kamel ^a   Amini, Shohreh ^a   Reiss, Krzysztof ^a  

^a Temple University   (United States)

Author keywords

HIV associated dementia; IGF I; Neuronal damage; Neuronal survival; TNF

Indexed keywords

COMPLEMENTARY DNA; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; BRAIN INJURY; CELL DIFFERENTIATION; CELL STRAIN; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MEDIATOR RELEASE; MICROGLIA; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037225431     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1690     Document Type: Article

References (56)

1. Baeuerle, P. A., and Baltimore, D. (1988). I kappa B: A specific inhibitor of the NF-kappa B transcription factor. Science 242(4878), 540-546.
2. Boone, E., Vanden Berghe, T., Van Loo, G., De Wilde, G., De Wael, N., Vercammen, D., Fiers, W., Haegeman, G., and Vandenabeele, P. (2000). Structure/function analysis of p55 tumor necrosis factor receptor and fas-associated death domain. Effect on necrosis in L929sA cells. J. Biol. Chem. 275(48), 37596-37603.
3. Boone, E., Vandevoorde, V., De Wilde, G., and Haegeman, G. (1998). Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor. FEBS Lett. 441(2), 275-280.
4. Budka, H., Costanzi, G., Cristina, S., Lechi, A., Parravicini, C., Trabattoni, R., and Vago, L. (1987). Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol. (Berlin) 75(2), 185-198.
5. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., and Reed, J. C. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282(5392), 1318-1321.
6. D'Mello, S. R., Galli, C., Ciotti, T., and Calissano, P. (1993). Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA 90(23), 10989-10993.
7. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. (1997). Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275(5300), 661-665.
8. Frost, R. A., Fuhrer, J., Steigbigel, R., Mariuz, P., Lang, C. H., and Gelato, M. C. (1996). Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin. Endocrinol. (Oxford) 44(5), 501-514.
9. Furusu, A., Nakayama, K., Xu, Q., Konta, T., Sugiyama, H., and Kitamura, M. (2001). Expression, regulation, and function of inhibitor of apoptosis family genes in rat mesangial cells. Kidney Int. 60(2), 579-586.
10. Gabuzda, D. H., and Hirsch, M. S. (1987). Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. Ann. Intern. Med. 107(3), 383-391.
11. Gary, D. S., Bruce-Keller, A. J., Kindy, M. S., and Mattson, M. P. (1998). Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 18 (12), 1283-1287.
12. Glass, J. D., and Johnson, R. T. (1996). Human immunodeficiency virus and the brain. Annu. Rev. Neurosci. 19, 1-26.
13. Gluckman, P., Klempt, N., Guan, J., Mallard, C., Sirimanne, E., Dragunow, M., Klempt, M., Singh, K., Williams, C., and Nikolics, K. (1992). A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182(2), 593-599.
14. Hawley, R. G., Lieu, F. H., Fong, A. Z., and Hawley, T. S. (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1(2), 136-138.
15. Hotamisligil, G. S. (1999). The role of TNFalpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245(6), 621-625.
16. Jain, S., Golde, D. W., Bailey, R., and Geffner, M. E. (1998). Insulin-like growth factor-I resistance. Endocr. Rev. 19(5), 625-646.
17. Jones-Villeneuve, E. M., McBurney, M. W., Rogers, K. A., and Kalnins, V. I. (1982). Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell. Biol. 94(2), 253-262.
18. Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., and Tschopp, J. (2000). The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr. Biol. 10(11), 640-648.
19. Kaul, M., and Lipton, S. A. (1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96(14), 8212-8216.
20. Kubota, T., Miyagishima, M., Frye, C. S., Alber, S. M., Bounoutas, G. S., Kadokami, T., Watkins, S. C., McTiernan, C. F., and Feldman, A. M. (2001). Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium. J. Mol. Cell Cardiol. 33(7), 1331-1344.
21. Laue, L., Pizzo, P. A., Butler, K., and Cutler, G. B., Jr. (1990). Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome. J. Pediatr. 117(4), 541-545.
22. Lieberson, R., Mowen, K. A., McBride, K. D., Leautaud, V., Zhang, X., Suh, W. K., Wu, L., and Glimcher, L. H. (2001). Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45). J. Exp. Med. 194(1), 89-98.
23. Lo, J. C., Mulligan, K., Noor, M. A., Schwarz, J. M., Halvorsen, R. A., Grunfeld, C., and Schambelan, M. (2001). The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J. Clin. Endocr. Metab. 86(8), 3480-3487.
24. Locksley, R. M., Killeen, N., and Lenardo, M. J. (2001). The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104(4), 487-501.
25. Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., and Tschopp, J. (2001). NF-kappaB signals induce the expression of c-FLIP. Mol. Cell Biol. 21(16), 5299-5305.
26. Mynarcik, D. C., Frost, R. A., Lang, C. H., DeCristofaro, K., McNurlan, M. A., Garlick, P. J., Steigbigel, R. T., Fuhrer, J., Ahnn, S., and Gelato, M. C. (1999). Insulin-like growth factor system in patients with HIV infection: Effect of exogenous growth hormone administration. J. Acquir. Immune Defic. Syndr. 22(1), 49-55.
27. Mynarcik, D. C., McNurlan, M. A., Steigbigel, R. T., Fuhrer, J., and Gelato, M. C. (2000). Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J. Acquir. Immune Defic. Syndr. 25(4), 312-321.
28. Natoli, G., Costanzo, A., Guido, F., Moretti, F., and Levrero, M. (1998). Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. Biochem. Pharmacol. 56(8), 915-920.
29. Panka, D. J., Mano, T., Suhara, T., Walsh, K., and Mier, J. W. (2001). Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J. Biol. Chem. 276(10), 6893-6896.
30. Peraldi, P., Hotamisligil, G. S., Buurman, W. A., White, M. F., and Spiegelman, B. M. (1996). Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 271(22), 13018-13022.
31. Peruzzi, F., Prisco, M., Dews, M., Salomoni, P., Grassilli, E., Romano, G., Calabretta, B., and Baserga, R. (1999). Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol. Cell Biol. 19(10), 7203-7215.
32. Peruzzi, F., Prisco, M., Morrione, A., Valentinis, B., and Baserga, R. (2001). Anti-apoptotic signaling of the IGF-I receptor through mitochondrial translocation of c-Raf and Nedd4. J. Biol. Chem. 14, 14.
33. Price, R. W. (1988). Dementia associated with AIDS. Trans. Assoc. Life Insur. Med. Dir. Am. 71, 235-240.
34. Price, R. W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A. C., and Cleary, P. (1988). The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex. Science 239(4840), 586-592.
35. Reiss, K., Valentinis, B., Tu, X., Xu, S. Q., and Baserga, R. (1998). Molecular markers of IGF-I-mediated mitogenesis. Exp. Cell Res. 242(1), 361-372.
36. Rieckmann, P., Poli, G., Fox, C. H., Kehrl, J. H., and Fauci, A. S. (1991). Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J. Immunol. 147(9), 2922-2927.
37. Rimaniol, A. C., Boussin, F. D., Dormont, D., Bach, J. F., and Zavala, F. (1997). Mechanisms of downmodulation and release of tumour necrosis factor receptor induced by human immunodeficiency virus type 1 in human monocytes. Cytokine 9(1), 9-18.
38. Romano, G., Prisco, M., Zanocco-Marani, T., Peruzzi, F., Valentinis, B., and Baserga, R. (1999). Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling. J. Cell. Biochem. 72(2), 294-310.
39. Sharer, L. R. (1992). Pathology of HIV-1 infection of the central nervous system. A review. J. Neuropathol. Exp. Neurol. 51(1), 3-11.
40. Sippy, B. D., Hofman, F. M., Wallach, D., and Hinton, D. R. (1995). Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10(5), 511-521.
41. Tan, S. V., Guiloff, R. J., Henderson, D. C., Gazzard, B. G., and Miller, R. (1996). AIDS-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNF alpha). J. Neurol. Sci. 138(1-2), 134-144.
42. Teng, K. K., Georgieff, I. S., Aletta, J. M., Nunez, J., Shelanski, M. L., and Greene, L. A. (1993). Characterization of a PC12 cell sub-clone (PC12-C41) with enhanced neurite outgrowth capacity: Implications for a modulatory role of high molecular weight tau in neuritogenesis. J. Cell. Sci. 106(Pt. 2), 611-626.
43. Thompson, K. A., McArthur, J. C., and Wesselingh, S. L. (2001). Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann. Neurol. 49(6), 745-752.
44. Valentinis, B., Navarro, M., Zanocco-Marani, T., Edmonds, P., McCormick, J., Morrione, A., Sacchi, A., Romano, G., Reiss, K., and Baserga, R. (2000). Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J. Biol. Chem. 275(33), 25451-25459.
45. Valentinis, B., Reiss, K., and Baserga, R. (1998). Insulin-like growth factor-I-mediated survival from anoikis: Role of cell aggregation and focal adhesion kinase. J. Cell. Physiol. 176(3), 648-657.
46. Venters, H. D., Tang, Q., Liu, Q., VanHoy, R. W., Dantzer, R., and Kelley, K. W. (1999). A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc. Natl. Acad. Sci. USA 96(17), 9879-9884.
47. Wallach, D. (1997). Cell death induction by TNF: A matter of self control. Trends Biochem. Sci. 22(4), 107-109.
48. Wang, J. Y., Del Valle, L., Gordon, J., Rubini, M., Romano, G., Croul, S., Peruzzi, F., Khalili, K., and Reiss, K. (2001). Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas. Oncogene 20(29), 3857-3868.
49. Westmoreland, S. V., Kolson, D., and Gonzalez-Scarano, F. (1996). Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: A tissue culture model for human immunodeficiency virus dementia. J. Neurovirol. 2(2), 118-126.
50. You, Z., Ouyang, H., Lopatin, D., Polver, P. J., and Wang, C. Y. (2001). Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J. Biol. Chem. 276(28), 26398-26404.
51. Yu, S. F., von Ruden, T., Kantoff, P. W., Garber, C., Seiberg, M., Ruther, U., Anderson, W. F., Wagner, E. F., and Gilboa, E. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83(10), 3194-3198.
52. Yuan, J., and Yankner, B. A. (2000). Apoptosis in the nervous system. Nature 407(6805), 802-809.
53. Yuasa, T., Ohno, S., Kehrl, J. H., and Kyriakis, J. M. (1998). Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273(35), 22681-22692.
54. Zandi, E., Chen, Y., and Karin, M. (1998). Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: Discrimination between free and NF-kappaB-bound substrate. Science 281(5381), 1360-1363.
55. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87(4), 619-628.
56. Zheng, W. H., Kar, S., Dore, S., and Quirion, R. (2000). Insulin-like growth factor-1 (IGF-1): A neuroprotective trophic factor acting via the Akt kinase pathway. J. Neural Transm. Suppl. (60), 261-272.